KALA BIO, Inc. — Form 8-K
Filed September 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
KALA BIO filed an 8-K on September 9, 2026 disclosing Item 5.08 (Shareholder Nominations pursuant to Exchange Act Rule 14a-11) and Item 8.01 (Other Events). The filing provides no specific dollar amounts, counterparties, transaction details, or concrete facts—only regulatory headers and metadata. The actual substantive disclosure content is not included in the provided filing text.
Why this rating
Shareholder nomination disclosure is routine governance procedural filing. Without substantive details (nominee identity, vote details, or contestation), impact is administrative. Neutral: governance process, not business operations.
Extracted items
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.